BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 33193357)

  • 21. Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation.
    Shen ZH; Zhu CX; Quan YS; Yang ZY; Wu S; Luo WW; Tan B; Wang XY
    World J Gastroenterol; 2018 Jan; 24(1):5-14. PubMed ID: 29358877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity.
    Kinashi Y; Hase K
    Front Immunol; 2021; 12():673708. PubMed ID: 33968085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic effects of gut microbiota and its relationship with disease and modulation.
    Ho JT; Chan GC; Li JC
    BMC Immunol; 2015 Mar; 16():21. PubMed ID: 25896342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leveraging diet to engineer the gut microbiome.
    Wolter M; Grant ET; Boudaud M; Steimle A; Pereira GV; Martens EC; Desai MS
    Nat Rev Gastroenterol Hepatol; 2021 Dec; 18(12):885-902. PubMed ID: 34580480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Association of Gut Microbiota and Treg Dysfunction in Autoimmune Diseases.
    Liu Y; Tran DQ; Lindsey JW; Rhoads JM
    Adv Exp Med Biol; 2021; 1278():191-203. PubMed ID: 33523449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intestinal Dysbiosis and Rheumatoid Arthritis: A Link between Gut Microbiota and the Pathogenesis of Rheumatoid Arthritis.
    Horta-Baas G; Romero-Figueroa MDS; Montiel-Jarquín AJ; Pizano-Zárate ML; García-Mena J; Ramírez-Durán N
    J Immunol Res; 2017; 2017():4835189. PubMed ID: 28948174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbiome Regulation of Autoimmune, Gut and Liver Associated Diseases.
    Singh B; Qin N; Reid G
    Inflamm Allergy Drug Targets; 2015; 14(2):84-93. PubMed ID: 26817477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation.
    Elangovan A; Allegretti JR; Fischer M
    Expert Opin Biol Ther; 2019 Dec; 19(12):1343-1355. PubMed ID: 31570017
    [No Abstract]   [Full Text] [Related]  

  • 29. Is there a role for gut microbiota in type 1 diabetes pathogenesis?
    Bibbò S; Dore MP; Pes GM; Delitala G; Delitala AP
    Ann Med; 2017 Feb; 49(1):11-22. PubMed ID: 27499366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The autoimmunity-oral microbiome connection.
    Nikitakis NG; Papaioannou W; Sakkas LI; Kousvelari E
    Oral Dis; 2017 Oct; 23(7):828-839. PubMed ID: 27717092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal microbiota transplantation for managing irritable bowel syndrome.
    El-Salhy M; Mazzawi T
    Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):439-445. PubMed ID: 29493330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
    Babickova J; Gardlik R
    World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Microbiota and irritable bowel syndrome: A critical inventory].
    Enck P; Mazurak N
    Z Gastroenterol; 2019 Jul; 57(7):859-870. PubMed ID: 31288282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature.
    Giuffrè M; Campigotto M; Campisciano G; Comar M; Crocè LS
    Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G889-G906. PubMed ID: 32146836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbe-metabolite-host axis, two-way action in the pathogenesis and treatment of human autoimmunity.
    Meng X; Zhou HY; Shen HH; Lufumpa E; Li XM; Guo B; Li BZ
    Autoimmun Rev; 2019 May; 18(5):455-475. PubMed ID: 30844549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The human microbiome in rheumatic autoimmune diseases: A comprehensive review.
    Coit P; Sawalha AH
    Clin Immunol; 2016 Sep; 170():70-9. PubMed ID: 27493014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal microbiota transfer for bowel disorders: efficacy or hype?
    Schmulson M; Bashashati M
    Curr Opin Pharmacol; 2018 Dec; 43():72-80. PubMed ID: 30218939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Gut-Eye Axis: Correlation Between the Gut Microbiota and Autoimmune Dry Eye in Individuals With Sjögren Syndrome.
    Bai X; Xu Q; Zhang W; Wang C
    Eye Contact Lens; 2023 Jan; 49(1):1-7. PubMed ID: 36544282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.